Events By Category | Events By Hotbed | Event News | Search Events
Event Name2017 1st First EASL Nonalcoholic Fatty Liver Disease (NAFLD) Summit
Event Date(s) Thursday, November 09, 2017  to Saturday, November 11, 2017
Event Location Radisson Blu ES. Hotel Via
Rome,
Italy
CostN/A
DescriptionThis summit will cover both the basic and translational / clinical aspects of NAFLD, with a specific focus on novel drug target and prognostic signature development.

Who Should Attend:

• Basic and translational scientists
• Clinical researchers
• Industry / Biotechnology
• Hepatologists
• Health professionals
• Regulatory and funding agencies
• Young researchers and trainees

Why Attend?

• Presentations from Academia and Industry
• Dedicated to translational science
• Encourage collaboration between Academia and Industry
• Identifying future areas for drug development

Topics to be covered:

NAFLD pathogenesis, patient management, prognostic and therapeutic targets, non-invasive assessment of fibrosis, apoptosis, biomarkers, insulin resistance and signalling, hormonal and bile acids signalling, oxidative and mitochondrial stress, inflammation and immunity in NASH, carcinogenesis, gut microbiota.
SponsorRebound Therapeutics
Host CompanyRebound Therapeutics
Contact Information Phone: +39-02566011
Fax:   N/A 
Email: aifa@aimgroup.eu
More Information http://www.easl.eu/discover/events/detail/2017/first-easl-nafld-summit-target-oriented-approach-to-diagnosis-and-pharmacotherapy-of-nash-a-dialogue-between-academia-and-industry
 
//-->